RHUMBLINE ADVISERS

Position in GILD — Gilead Sciences, Inc.

CIK 1115418 BOSTON, MA

Back to GILD Full portfolio

Position in GILD

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$311,674,803

+$32,922,567 QoQ

Shares Held

2,236,312

-1.5% QoQ

Ownership

0.180%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 58.90694142856632.ToString("F0")% Shared 0.ToString("F0")% None 41.09305857143368.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $4,442,669,348 across 18 Drug Manufacturers - General names. GILD ranks #6 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,358,698	$1,249,689,659
2	JNJ	Johnson & Johnson	3,829,150	$935,997,426
3	ABBV	AbbVie Inc.	2,897,983	$630,282,322
4	MRK	Merck & Co., Inc.	3,797,430	$456,792,854
5	AMGN	Amgen Inc	914,016	$321,596,529
6	GILD	Gilead Sciences, Inc. This page	2,236,312	$311,674,803
7	PFE	Pfizer Inc	8,875,485	$249,223,618
8	BMY	Bristol Myers Squibb Co	3,647,568	$221,224,999

All Filings in GILD

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$311,674,803	2,236,312	-1.5%	Shares	Sole	2026-05-12
2025-12-31	$278,752,236	2,271,079	-2.4%	Shares	Sole	2026-02-13
2025-09-30	$258,393,126	2,327,866	-0.7%	Shares	Sole	2025-11-06
2025-06-30	$259,820,297	2,343,468	+3.9%	Shares	Sole	2025-08-12
2025-03-31	$252,688,437	2,255,140	-2.9%	Shares	Sole	2025-05-29
2024-12-31	$214,631,116	2,323,602	-1.7%	Shares	Sole	2025-05-29
2024-09-30	$198,142,509	2,363,341	-3.9%	Shares	Sole	2024-11-12
2024-06-30	$168,746,295	2,459,500	-0.0%	Shares	Sole	2024-08-01
2024-03-31	$180,234,408	2,460,538	-12.8%	Shares	Sole	2024-05-09
2023-12-31	$228,625,611	2,822,190	-1.4%	Shares	Sole	2024-02-08
2023-09-30	$214,486,448	2,862,109	+2.6%	Shares	Sole	2023-11-09
2023-06-30	$214,992,468	2,789,574	-0.1%	Shares	Sole	2023-08-08
2023-03-31	$231,714,467	2,792,750	+2.0%	Shares	Sole	2023-05-11
2022-12-31	$234,953,335	2,736,789	+1.6%	Shares	Sole	2023-02-14
2022-09-30	$166,191,626	2,693,980	+19.9%	Shares	Sole	2022-11-10
2022-06-30	$138,831,811	2,246,106	+5.0%	Shares	Sole	2022-08-11
2022-03-31	$127,168,722	2,139,087	+1.6%	Shares	Sole	2022-05-12
2021-12-31	$152,838,604	2,104,925	+1.8%	Shares	Sole	2022-02-10
2021-09-30	$144,381,696	2,067,025	-3.1%	Shares	Sole	2021-11-12
2021-06-30	$146,945,449	2,133,974	-5.5%	Shares	Sole	2021-08-05
2021-03-31	$145,930,920	2,257,944	-5.1%	Shares	Sole	2021-05-06
2020-12-31	$138,615,804	2,379,262	-5.3%	Shares	Sole	2021-02-10
2020-09-30	$158,682,664	2,511,199	-0.3%	Shares	Sole	2020-11-12
2020-06-30	$193,781,314	2,518,603	+12.1%	Shares	Sole	2020-08-13
2020-03-31	$168,001,569	2,247,212	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.